Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.

[1]  D. Margolis,et al.  Lack of Association between Exposure to Topical Calcineurin Inhibitors and Skin Cancer in Adults , 2007, Dermatology.

[2]  C. Paul,et al.  Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. , 2007, The Journal of investigative dermatology.

[3]  G. Krueger,et al.  Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis. , 2007, Journal of drugs in dermatology : JDD.

[4]  M. Boguniewicz,et al.  10. Atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.

[5]  F. Kianifard,et al.  Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis , 2006, The Journal of dermatological treatment.

[6]  A. Gottlieb,et al.  Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. , 2005, Journal of the American Academy of Dermatology.

[7]  E. Jaracz,et al.  Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. , 2005, Journal of the American Academy of Dermatology.

[8]  W. Abramovits.  A clinician's paradigm in the treatment of atopic dermatitis. , 2005, Journal of the American Academy of Dermatology.

[9]  N. Undre,et al.  Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis. , 2005, The Journal of investigative dermatology.

[10]  T. Bieber,et al.  A multicentre, randomized, double‐blind, controlled study of long‐term treatment with 0·1% tacrolimus ointment in adults with moderate to severe atopic dermatitis , 2005, The British journal of dermatology.

[11]  N. Undre,et al.  A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis. , 2005, The Journal of investigative dermatology.

[12]  A. Giannetti,et al.  The role of topical calcineurin inhibitors in atopic dermatitis: , 2004, The British journal of dermatology.

[13]  R. Damstra,et al.  Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study , 2003, BMJ : British Medical Journal.

[14]  A. Paller,et al.  Safe treatment of head/neck AD with Tacrolimus ointment , 2003 .

[15]  M. Meurer,et al.  Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study , 2002, Dermatology.

[16]  J. Hanifin,et al.  Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients , 2002, The British journal of dermatology.

[17]  U. Wahn,et al.  Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. , 2002, Pediatrics.

[18]  M. Lahfa,et al.  Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis , 2000 .

[19]  D. van der Meer,et al.  The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate , 1999, The British journal of dermatology.

[20]  B. Giannotti,et al.  Topical Corticosteroids and Unwanted Local Effects , 1994, Drug safety.

[21]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[22]  A. Fleischer,et al.  Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. , 2001, Journal of the American Academy of Dermatology.

[23]  Sewon Kang,et al.  Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. , 2001, Journal of the American Academy of Dermatology.

[24]  A. Paller,et al.  A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. , 2001, Journal of the American Academy of Dermatology.

[25]  Sewon Kang,et al.  Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children. , 1998, Journal of the American Academy of Dermatology.